PlainRecalls
FDA Devices Moderate Class II Ongoing

Smart Toe II Intramedullary Arthrodesis Implant

Reported: May 4, 2022 Initiated: March 28, 2022 #Z-1011-2022

Product Description

Smart Toe II Intramedullary Arthrodesis Implant

Reason for Recall

The nickel-sensitivity statement on the outer carton may be partially covered by a label resulting in the statement showing "Indicated for patients with Nickel sensitivity" instead of "Not Indicated for patients with Nickel sensitivity".

Details

Recalling Firm
Stryker GmbH
Units Affected
246 implants
Distribution
Worldwide distribution - US Nationwide and the countries including Australia, Canada, Chile, China, France, Germany, Netherlands, New Zealand, Spain, Sweden, Switzerland, and United Kingdom.
Location
Selzach

Frequently Asked Questions

What product was recalled?
Smart Toe II Intramedullary Arthrodesis Implant. Recalled by Stryker GmbH. Units affected: 246 implants.
Why was this product recalled?
The nickel-sensitivity statement on the outer carton may be partially covered by a label resulting in the statement showing "Indicated for patients with Nickel sensitivity" instead of "Not Indicated for patients with Nickel sensitivity".
Which agency issued this recall?
This recall was issued by the FDA Devices on May 4, 2022. Severity: Moderate. Recall number: Z-1011-2022.